No differences in myocardial perfusion between treatment‐naive, early rheumatoid arthritis patients and healthy controls

Saved in:
Bibliographic Details
Published inArthritis & rheumatology (Hoboken, N.J.) Vol. 75; no. 1; pp. 141 - 142
Main Authors Biglands, John D., Erhayiem, Bara, Fent, Graham, Greenwood, John P., Dumitru, Raluca B., Andrews, Jacqueline, Emery, Paul, Buch, Maya H., Plein, Sven
Format Journal Article
LanguageEnglish
Published Boston, USA Wiley Periodicals, Inc 01.01.2023
Wiley Subscription Services, Inc
Subjects
Arthritis
Arthritis, Rheumatoid - drug therapy
Case-Control Studies
Humans
Perfusion
Rheumatoid arthritis
Online AccessGet full text

Cover

More Information
Bibliography:https://onlinelibrary.wiley.com/action/downloadSupplement?doi=10.1002%2Fart.42341&file=art42341‐sup‐0001‐Disclosureform.pdf
.
Supported by the National Institute for Health Research (Efficacy Mechanism Evaluation grant 11/117/27). The parent study, VEDERA, was supported by Pfizer through an investigator sponsored research grant (WS1092499). This article presents independent research supported by the National Institute for Health Research Leeds Biomedical Research Centre. Dr. Biglands’ work was funded by the National Institute for Health Research and Health Education England Clinical Lectureship (grants 14607, ICA‐CL‐2016‐02‐017). Author disclosures are available at
SourceType-Other Sources-1
ObjectType-Article-2
content type line 63
ObjectType-Correspondence-1
ISSN:2326-5191
2326-5205
DOI:10.1002/art.42341